Docetaxel [docetaxel]
topical
179
- Terms
-
Docetaxel Anhydrous
Docetaxel Hydrate
Docetaxel Trihydrate
Docetaxol
N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol
NSC 628503
RP 56976
RP-56976
Taxoltere Metro
Taxotere
Persistent link
https://www.medvik.cz/link/D000077143
Definition
A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER.
- DUI
- D000077143 MeSH Browser
- CUI
- M0184558
- CAS
- Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, (2aR,4S,4aR,6R,9S,11S,12S,12aS,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,4a ,6,11-tetrahydroxy-8,12a,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR)-, hydrate (1:3)
- History note
- 2019 (1991)
- Public note
- 2019; DOCETAXEL was indexed under TAXOIDS 1993-2018, and under ALKALOIDS 1991-1992
Allowable subheadings
- AD
- administration & dosage 25
- AE
- adverse effects 12
- AG
- agonists
- AA
- analogs & derivatives 3
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 2
- CL
- classification 1
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 27
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 69
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records